Compare PRVA & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRVA | HUN |
|---|---|---|
| Founded | 2007 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Major Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.6B |
| IPO Year | 2021 | 2004 |
| Metric | PRVA | HUN |
|---|---|---|
| Price | $22.77 | $14.53 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 11 |
| Target Price | ★ $31.17 | $12.09 |
| AVG Volume (30 Days) | 967.7K | ★ 4.9M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.64% |
| EPS Growth | ★ 63.64 | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | $2,122,842,000.00 | ★ $5,683,000,000.00 |
| Revenue This Year | $18.19 | $3.08 |
| Revenue Next Year | $10.72 | $5.27 |
| P/E Ratio | $1,132.50 | ★ N/A |
| Revenue Growth | ★ 22.26 | N/A |
| 52 Week Low | $18.78 | $7.30 |
| 52 Week High | $26.51 | $15.90 |
| Indicator | PRVA | HUN |
|---|---|---|
| Relative Strength Index (RSI) | 44.50 | 55.53 |
| Support Level | $21.47 | $13.10 |
| Resistance Level | $24.74 | $15.60 |
| Average True Range (ATR) | 0.90 | 0.63 |
| MACD | -0.15 | -0.08 |
| Stochastic Oscillator | 42.04 | 59.72 |
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. The product portfolio of the company comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, and others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. The company derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.